Researchers conducted a four-year follow-up on 52 patients with full-thickness cartilage defects who were treated with BioSeed-C. Nearly all patients showed significant improvement in the Lysholm score, International Knee Documentation Committee score, International Cartilage Repair Society score and Knee Injury Osteoarthritis Outcome Score
In the MRI evaluations, researchers found a moderate to complete defect filling in 43 of the 44 treated patients. There were two patients without clinical and MRI improvements and they received a total knee endoprosthesis after four years. The Isokinetic evaluation reported a significantly reduced maximum strength capacity for knee flexion and extension.
Read the abstract about BioSeed-C.
Read Articles Related to Cartilage Regeneration:
U.S. Cartilage Repair Market to Grow 6.8% Over Next 4 Years
Study: Matrix-Induced Autologous Chondrocyte Implantation Suitable for Treating Knee Cartilage Defects
Dr. Brian Cole Uses an Adolescent Donor for Cartilage Restoration on Professional Wrestler
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
